Results 221 to 230 of about 258,301 (250)

COPD

Chest, 2000
Norbert F. Voelkel, Rubin Tuder
openaire   +2 more sources

Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis

Lancet Respiratory Medicine,the, 2022
Davies Adeloye, Peige Song, Harry Campbell   +2 more
exaly  

Expertentreffen COPD: Exazerbation der COPD

Pneumologie, 2017
J. Lorenz, R. Bals, M. Dreher, B. Jany, R. Koczulla, M. Pfeifer, W. Randerath, G. Steinkamp, C. Taube, H. Watz, W. Windisch   +10 more
openaire   +1 more source

Progress in the mechanism and targeted drug therapy for COPD

Signal Transduction and Targeted Therapy, 2020
Atsushi Fukunaga
exaly  

Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts

New England Journal of Medicine, 2023
Alberto A Papi
exaly  

International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study

Lancet, The, 2007
David M Mannino, Ana M B Menezes, Sean D Sullivan   +2 more
exaly  

New treatments for copd

Nature Reviews Drug Discovery, 2002
Peter J Barnes
exaly  

COPD

2010
B. Schönhofer, D. Dellweg
openaire   +1 more source

Burden and clinical features of chronic obstructive pulmonary disease (COPD)

Lancet, The, 2004
Klaus F Rabe
exaly  

COPD

2023
openaire   +1 more source